← Back to headlines
Sutro Biopharma Reports Mixed Financial Results for Q4
Sutro Biopharma announced GAAP EPS of -$22.49, missing estimates, but reported revenue of $102.48 million, which beat expectations.
23 Mar, 20:14 — 23 Mar, 20:14
Sources
Showing 1 of 1 sources
